Correction to: Signal Transduction and Targeted Therapy 10.1038/s41392-023-01482-9, published online 22 May 2023
In our recent review of the article [1], the author noticed that the dots (red squares) in Fig 1m were accidentally removed from its original location during figure formatting, and the related data analysis is correct. Furthermore, we checked this paper again and this situation only occurred in Fig 1m. In addition, in Fig 1c, a legend for SARS-CoV-1 is missing and we have supplemented it. For the text section, no modifications are required. The correct data are provided as follows. The key findings of the article are not affected by these corrections. The original article has been corrected. We regret any inconvenience this has caused.
-
In Fig 1c, a legend for SARS-CoV-1 is missing. The correct image is as below.
Fig 1c Compound JZD-07 is a potent inhibitor of SARS-CoV-2 3CLpro as well as SARS-CoV-1 3CLpro.
In Fig 1m, the dots (red squares) were accidentally removed from its original location during figure formatting, and the related data analysis is correct. The correct image is as below.
Fig 1m Viral RNA copies and viral titers in lung tissues of each group were determined on day 2 after the SARS-CoV-2 delta variant challenge (**P ≤ 0.01).
The original article has been corrected.
Contributor Information
Haixia Su, Email: suhaixia1@simm.ac.cn.
Leike Zhang, Email: zhangleike@wh.iov.cn.
Yi Zang, Email: yzang@lglab.ac.cn.
Yu Zhou, Email: zhouyu@simm.ac.cn.